3 completed. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
Follow rubitecan: new trials by email Literature Review of rubitecan trials Research Report on rubitecan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Aerosol L9-NC and Temozolomide in Ewing's Sarcoma Temozolomide, L9-NC - Ewing's Sarcoma | Phase 1 / Phase 2 | Completed | M.D. Anderson Cancer Center | 10 | 2006-06-01 | 2012-08-02 |
| Study of Rubitecan in Cancer Patients With Renal or Hepatic Dysfunction Rubitecan - Tumors | Phase 1 | Completed | Astex Pharmaceuticals, Inc. | 54 | 2001-08-01 | 2024-08-02 |
| Combination Therapy With Oral 9-Nitrocamptothecin & Oral Etoposide Oral Etoposide, Oral 9-Nitrocamptothecin - Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Completed | H. Lee Moffitt Cancer Center and Research Institute | 44 | 2000-06-01 | 2012-09-26 |
Liver Diseases (1) · Neoplasms (1) · Renal Insufficiency (1) · Sarcoma, Ewing (1)
Astex Pharmaceuticals, Inc. (1) · H. Lee Moffitt Cancer Center and Research Institute (1) · M.D. Anderson Cancer Center (1)
United States (3)